9 junio 2015
In a small clinical trial, scientists found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 respond to chemotherapy just as well as men who lack the variant.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ISc7MQdS2ZU/150609141732.htm
